The patent badge is an abbreviated version of the USPTO patent document. The patent badge does contain a link to the full patent document.

The patent badge is an abbreviated version of the USPTO patent document. The patent badge covers the following: Patent number, Date patent was issued, Date patent was filed, Title of the patent, Applicant, Inventor, Assignee, Attorney firm, Primary examiner, Assistant examiner, CPCs, and Abstract. The patent badge does contain a link to the full patent document (in Adobe Acrobat format, aka pdf). To download or print any patent click here.

Date of Patent:
Dec. 26, 2017

Filed:

Dec. 16, 2009
Applicants:

John Andrew Chaddock, Abingdon, GB;

Keith Alan Foster, Abingdon, GB;

Inventors:

John Andrew Chaddock, Abingdon, GB;

Keith Alan Foster, Abingdon, GB;

Assignee:

Ipsen Bioinnovation Limited, Abingdon, Oxfordshire, GB;

Attorney:
Primary Examiner:
Int. Cl.
CPC ...
A61K 38/48 (2006.01); C12N 9/50 (2006.01); C12N 9/52 (2006.01); A61K 38/00 (2006.01);
U.S. Cl.
CPC ...
A61K 38/4893 (2013.01); C12N 9/50 (2013.01); C12N 9/52 (2013.01); C12Y 304/24069 (2013.01); A61K 38/00 (2013.01); C07K 2319/06 (2013.01); C07K 2319/33 (2013.01); C07K 2319/50 (2013.01);
Abstract

The present invention relates to a modified polypeptide comprising a non-cytotoxic protease, a translocation domain, a destructive protease cleavage site and a Targeting Moiety that binds to a Binding Site on a nerve cell, wherein after cleavage of the destructive cleavage site the polypeptide has reduced potency. The destructive cleavage site is recognized and cleaved by a protease present at or in an off-site target cell, and, in one embodiment, the polypeptide is a modified clostridial neurotoxin. The present invention also relates to the use of said polypeptides for treating a range of conditions, and to nucleic acids encoding said polypeptides.


Find Patent Forward Citations

Loading…